286 related articles for article (PubMed ID: 25329461)
1. Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4).
Key FM; Peter B; Dennis MY; Huerta-Sánchez E; Tang W; Prokunina-Olsson L; Nielsen R; Andrés AM
PLoS Genet; 2014 Oct; 10(10):e1004681. PubMed ID: 25329461
[TBL] [Abstract][Full Text] [Related]
2. IFN-λ4: the paradoxical new member of the interferon lambda family.
O'Brien TR; Prokunina-Olsson L; Donnelly RP
J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
[TBL] [Abstract][Full Text] [Related]
3.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract][Full Text] [Related]
4. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
Bhushan A; Chinnaswamy S
Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
[TBL] [Abstract][Full Text] [Related]
5. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
[TBL] [Abstract][Full Text] [Related]
6. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600
[TBL] [Abstract][Full Text] [Related]
7. IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
Eslam M; McLeod D; Kelaeng KS; Mangia A; Berg T; Thabet K; Irving WL; Dore GJ; Sheridan D; Grønbæk H; Abate ML; Hartmann R; Bugianesi E; Spengler U; Rojas A; Booth DR; Weltman M; Mollison L; Cheng W; Riordan S; Mahajan H; Fischer J; Nattermann J; Douglas MW; Liddle C; Powell E; Romero-Gomez M; George J;
Nat Genet; 2017 May; 49(5):795-800. PubMed ID: 28394349
[TBL] [Abstract][Full Text] [Related]
8. Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
Waldenström J; Hellstrand K; Westin J; Nilsson S; Christensen P; Färkkilä M; Mørch K; Langeland N; Norkrans G; Lagging M
Scand J Gastroenterol; 2021 Jul; 56(7):849-854. PubMed ID: 34078234
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
Front Immunol; 2021; 12():692263. PubMed ID: 34497603
[No Abstract] [Full Text] [Related]
10. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
11. The
Zhou H; Møhlenberg M; Terczyńska-Dyla E; Winther KG; Hansen NH; Vad-Nielsen J; Laloli L; Dijkman R; Nielsen AL; Gad HH; Hartmann R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776283
[TBL] [Abstract][Full Text] [Related]
12. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
O'Brien TR; Jackson SS
J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
[TBL] [Abstract][Full Text] [Related]
13. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
[TBL] [Abstract][Full Text] [Related]
14. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S
PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784
[TBL] [Abstract][Full Text] [Related]
15. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
Bharatiya S; Agarwal A; Chinnaswamy S
J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
[TBL] [Abstract][Full Text] [Related]
16. Genetics of the Human Interferon Lambda Region.
Prokunina-Olsson L
J Interferon Cytokine Res; 2019 Oct; 39(10):599-608. PubMed ID: 31070498
[TBL] [Abstract][Full Text] [Related]
17. Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.
Ansari MA; Aranday-Cortes E; Ip CL; da Silva Filipe A; Lau SH; Bamford C; Bonsall D; Trebes A; Piazza P; Sreenu V; Cowton VM; ; Hudson E; Bowden R; Patel AH; Foster GR; Irving WL; Agarwal K; Thomson EC; Simmonds P; Klenerman P; Holmes C; Barnes E; Spencer CC; McLauchlan J; Pedergnana V
Elife; 2019 Sep; 8():. PubMed ID: 31478835
[TBL] [Abstract][Full Text] [Related]
18. IFNL4/IL-28B haplotype structure and its impact on susceptibility to hepatitis C virus and treatment response in the Japanese population.
Ochi H; Miki D; Hayes CN; Abe H; Hayashida Y; Kubo M; Chayama K
J Gen Virol; 2014 Jun; 95(Pt 6):1297-1306. PubMed ID: 24646752
[TBL] [Abstract][Full Text] [Related]
19. The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.
Onabajo OO; Muchmore B; Prokunina-Olsson L
J Interferon Cytokine Res; 2019 Oct; 39(10):636-641. PubMed ID: 31241411
[TBL] [Abstract][Full Text] [Related]
20. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]